Search Results - "Koumarianou, A"

Implications of thymidylate synthase gene polymorphisms, KRAS and BRAF mutations in the survival of patients with colorectal cancer treated with adjuvant chemotherapy by Ntavatzikos, A, Spathis, A, Patapis, P, Peros, G, Panayiotides, I, Papadopoulos, I, Koumarianou, A

Get full text

ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors by Borbath, Ivan, Pape, Ulrich‐Frank, Deprez, Pierre H., Bartsch, Detlef Klaus, Caplin, Martyn, Falconi, Massimo, Garcia‐Carbonero, Rocio, Grozinsky‐Glasberg, Simona, Jensen, Robert T., Arnold, Rudolf, Ruszniewski, Philippe, Toumpanakis, C., Valle, Juan W., O´Toole, Dermot, Belli, S. H., Castaño, J. P., Chen, J, Costa, F. P., Couvelard, A, de Herder, W. W., Deroose, C. M., Dromain, C, Faggiano, A, Falkerby, J, Fazio, N, Frilling, A, Grande, E., Hand, P, Hicks, R. J., Hörsch, D, Howe, J. R., Klöppel, G, Kolarova, T, Kos‐Kudła, B, Koumarianou, A, Krejs, G. J., Krenning, E. P., Krishna, B. A., Leyden, S, Masui, T, Niederle, B, Nieveen van Dijkum, E. J., Öberg, K, Pavel, M, Perren, A, Prasad, V, Ramage, J. K., Reed, N. S., Rindi, G, Gemelli, A, Rinke, A, Rothmund, M, Singh, S., Sundin, A, Velthuysen, M. F. van, Verslype, C, Vullierme, M. P., Welin, S, Wiedenmann, B, Zhao, H

“…Despite efforts from various endoscopy societies, reporting in the field of endoscopy remains extremely heterogeneous. Harmonisation of clinical practice in…”
Get full text

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer by Koumarianou, A., Makrantonakis, P., Zagouri, F., Papadimitriou, C., Christopoulou, A., Samantas, E., Christodoulou, C., Psyrri, A., Bafaloukos, D., Aravantinos, G., Papakotoulas, P., Baka, S., Andreadis, C., Alexopoulos, A., Bompolaki, I., Kampoli, Κ., Liori, S., Karvounis, K., Ardavanis, A.

“…Purpose The efficacy of nab -paclitaxel in patients with metastatic breast cancer (MBC) has been demonstrated in randomized clinical trials. However,…”
Get full text

PRIMARY BREAST LYMPHOMA: PATIENT CHARACTERISTICS, TREATMENT OPTIONS AND OUTCOMES: A MULTI‐CENTER STUDY OF THE HELLENIC COOPERATIVE LYMPHOMA GROUP by Bampali, V., Sioni, A., Arapaki, M., Sachanas, S., Spanoudakis, E., Giatra, C., Pentidou, A., Douna, S., Tsirogianni, M., Koumarianou, A., Barbarousi, D., Kotsopoulou, M., Kanellis, G., Vassilakopoulos, T., Pangalis, G., Bakiri, M., Pouli, A., Bouzani, M.

Get full text

Evaluation of the efficacy and safety of everolimus as a first-line treatment in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors by Koumarianou, A., Pectasides, D.G., Manousou, K., Dionysopoulos, D., Kaltsas, G.A., Kolomodi, D., Poulios, C., Skondra, M., Samantas, E., Pentheroudakis, G., Fountzilas, G.

Get full text

Depressive symptoms during adverse economic and political circumstances: A comparative study on Greek female breast cancer patients receiving chemotherapy treatment by Pelekasis, P., Kampoli, K., Ntavatzikos, A., Charoni, A., Tsionou, C., Koumarianou, A.

“…The aim of this study was to search for an effect of the adverse economic and political events that took place in 2015 in Greece (threat of bankruptcy,…”
Get full text

REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS by Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Giotas, A., Agathocleous, A., Kalpadakis, C., Akay, O., Atalar, S., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, C., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Get full text

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer by Pectasides, D, Xiros, N, Papaxoinis, G, Pectasides, E, Sykiotis, C, Koumarianou, A, Psyrri, A, Gaglia, A, Kassanos, D, Gouveris, P, Panayiotidis, J, Fountzilas, G, Economopoulos, T

“…Abstract Objectives The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in advanced or recurrent…”
Get full text

Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer by E. Fountzilas, J. Souglakos, J. Alafis, K. Dadouli, A. Koumarianou, N. Tsoukalas, A. Nikolaidi, D. Mauri, M. Karagianni, A. Anna, A. Psyrri, G. Rigakos, A. Avgerinos, M. Theochari, D. Pectasides, G. Oikonomopoulos, A. Vagionas, P. Papakostas, A. Christopoulou, G. Fountzilas, Z. Saridaki

“…Background: The superiority of paclitaxel/ramucirumab over alternative therapeutic regimens in patients with gastric cancer has yet to be defined. Our aim was…”
Get full text

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab by Koutras, A K, Antonacopoulou, A G, Eleftheraki, A G, Dimitrakopoulos, F-I, Koumarianou, A, Varthalitis, I, Fostira, F, Sgouros, J, Briasoulis, E, Bournakis, E, Bafaloukos, D, Bompolaki, I, Galani, E, Kalogeras, K T, Pectasides, D, Fountzilas, G, Kalofonos, H P

“…The aim of the study was to evaluate the association of vascular endothelial growth factor ( VEGF ) genotypes with treatment efficacy in a randomized trial…”
Get full text

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer by Carlsson, G., Koumarianou, A., Guren, T.K., Haux, J., Katsaounis, P., Kentepozidis, N., Pfeiffer, P., Brændengen, M., Mavroudis, D., Taflin, H., Skintemo, L., Tell, R., Papadimitriou, C.

“…5-fluorouracil (5-FU) combined with a folate remains an essential treatment component for metastatic colorectal cancer (mCRC). Leucovorin is the folate most…”
Get full text

2336 Clinical and therapeutic aspects of neuroendocrine tumors: The Greek NET Registry by Koumarianou, A, Nikou, G, Dimitroulopoulos, D, Alexandrakis, G, Papakostas, P, Vaslamatzis, M, Kaldrymidis, P, Markoussis, V, Pazaitou-Panayiotou, K

Get full text

RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES by Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadakis, C., Akay, O. M., Atalar, A. C., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T., Chatzidimitriou, C., Megalakaki, E., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Get full text

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R‐CHOP by Vassilakopoulos, Theodoros, Ferhanoglu, B, Horowitz, Na, Apostolidis, J, Mellios, Z, Piperidou, Alexia, Kaynar, L, Zektser, M, Giotasmater, A, Hospital, Dei, Malta, Msida, Symeonidis, A, Kalpadakis, C, Agathocleous, A, Akay, Om, Sayyed, A, Atalar, Sc, Katodritou, E, Leonidopoulou, T, Papageorgiou, Sg, Tadmor, T., Gutwein, O, Karakatsanis, S, Ganzel, C, Karianakis, G., Isenberg, G. Y., Gainaru, G, Vrakidou, E., Palassopoulou, M, Ozgur, M, Siakantaris, Marina, Paydas, S, Tsirigotis, P, Tsirogianni, M, Hatzimichael, E, Tugular, Tf, Assimakopoulos, Jv, Ligdi, L, Liaskas, A, Aikaterini Lefaki, Maria, Labropoulou, P, Kopsaftopoulou, A, Verrou, E, Kanellias, M, Zikos, P, Koumarianou, A, Gafter‐Gvili, A, Bouzani, M, Angelopoulou, Mk, Karmiris, T, Gurion, R

Get full text

miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects by RIZOS, E, SIAFAKAS, N, KOUMARIANOU, A, KATSANTONI, E, FILIPPOPOULOU, A, NTOUNAS, P, TOULOUMIS, Ch, KASTANIA, A, ZOUMPOURLIS, V

“…Previous studies have suggested that schizophrenia is associated with a reduced risk of cancer. Genes that are involved in cell cycle regulation seem to have…”
Get full text

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB‐DOSE‐ADJUSTED‐EPOCH(R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS by Vassilakopoulos, T., Piperidou, A., Mellios, Z., Verigou, E., Kalpadakis, C., Katodritou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, C., Leonidopoulou, T., Xanthopoulos, V., Karakatsanis, S., Gainaru, G., Vrakidou, E., Koumarianou, A., Hatzimichael, E., Verrou, E., Tsirogianni, M., Drandakis, I., Lefaki, M. A., Liaskas, A., Kopsaftopoulou, A., Lampropoulou, P., Kanellias, N., Zikos, P., Liapi, D., Karianakis, G., Grentzelias, D., Papadaki, E., Siakantaris, M., Tsirigotis, P., Panitsas, F., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Skoura, E., Angelopoulou, M., Symeonidis, A., Karmiris, T., Rontogianni, P.

Get full text

Complete Response after Imatinib Mesylate Administration in a Patient with Chemoresistant Stage IV Seminoma by PECTASIDES, D, NIKOLAOU, M, PECTASIDES, E, KOUMARIANOU, A, VALAVANIS, C, ECONOMOPOULOS, Th

“…The case of a young man with stage IV chemoresistant pure seminoma overexpressing KIT, who achieved complete remission (CR) after the administration of…”
Get full text

P1229: RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES by Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter‐Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.

Get full text

Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel — pretreated ovarian carcinoma by Pectasides, D, Pectasides, E, Papaxoinis, G, Psyrri, A, Pliarchopoulou, K, Koumarianou, A, Macheras, A, Athanasas, G, Xiros, N, Economopoulos, T

“…Abstract Objective In this phase II study the efficacy and toxicity of an alternating chemotherapy regimen was examined in platinum-resistant relapsed…”
Get full text

Survival Improvement of Young Patients, Aged 16-23, with Hodgkin Lymphoma (HL) during the Last Three Decades by KOUMARIANOU, A. A, XIROS, N, PAPAGEORGIOU, E, PECTASIDES, D, ECONOMOPOULOS, T

“…The prognostic factors, treatments and outcomes of 55 young adults (16-23 years old) with Hodgkin lymphoma (HL) treated in the Second Department of Internal…”
Get full text